【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, May 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, May 2013 9
2.2.1 Valeant Pharma to Acquire Bausch & Lomb for US$8.7 Billion 9
2.2.2 Actavis to Acquire Warner Chilcott for US$8.5 Billion 10
2.2.3 Royalty Pharma Increases Its Offer Price to Acquire Elan 10
2.2.4 Merck Completes Public Offering of Notes for $6.5 Billion 11
2.2.5 Pfizer Completes Public Offering of Notes for US$4 Billion 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, May 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, May 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, May 2013 14
3.1.1 Top M&A Deals in May 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, December 2012–May 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, May 2013 17
3.2.1 Top Equity Offering Deals in May 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, December 2012–May 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, May 2013 20
3.3.1 Top PE/VC Deals in May 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, May 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, May 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, December 2012–May 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, December 2012–May 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, May 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, May 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, December 2012–May 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), May 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, May 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), December 2012–May 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, December 2012–May 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), December 2012–May 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), December 2012–May 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, May 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, May 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), May 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, May 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, May 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, May 2013 38
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), December 2012–May 2013 39
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), December 2012–May 2013 40
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), December 2012–May 2013 41
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), December 2012–May 2013 43
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 44
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, May 2013 44
6.1.1 Oncology – Deals of the Month 45
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, May 2013 46
6.2.1 Central Nervous System – Deals of the Month 47
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, May 2013 48
6.3.1 Infectious Diseases – Deals of the Month 49
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, May 2013 50
6.4.1 Cardiovascular – Deal of the Month 51
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, May 2013 52
6.5.1 Metabolic Disorders – Deal of the Month 53
6.6 Pharmaceuticals & Healthcare, Global, Immunology Deals, May 2013 54
6.6.1 Immunology – Deal of the Month 55
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, May 2013 56
6.7.1 Respiratory – Deal of the Month 57
7 Deal Summary by Geography 58
7.1 Pharmaceuticals & Healthcare, North America Deals, May 2013 58
7.1.1 North America – Deals of the Month 59
7.2 Pharmaceuticals & Healthcare, Europe, Deals, May 2013 60
7.2.1 Europe – Deals of the Month 61
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, May 2013 62
7.3.1 Asia-Pacific – Deals of the Month 63
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, May 2013 64
7.4.1 Rest of the World – Deals of the Month 65
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 66
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, December 2012–May 2013 66
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, December 2012–May 2013 67
9 Further Information 68
9.1 Methodology 68
9.2 About GlobalData 69
9.3 Contact Us 69
9.4 Disclosure information 69
9.5 Disclaimer 69
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：May 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals
■ 発行日：2013年6月7日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161118
■ 調査対象地域：グローバル
- モデルマウスの世界市場：近交系マウス、ノックアウト・マウス、ハイブリッド・マウス、非近交系マウス、自然発生突然変異マウスThe global mice model market is segmented on the basis of type, technology, disease, service and mice care products. By type, the market is categorized into inbred mice, genetically modified mice (knockout, knock-in), conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice. The inbred mice are estimated to account for the largest share of the global ma …
- 加湿器の世界市場：ウォームミスト加湿機、クールミスト加湿機、超音波式加湿機About humidifier A humidifier is a device that helps to regulate humidity level in enclosed spaces and add moisture to the air when the humidity falls. Humidifier is used for residential, commercial, as well as industrial applications. It is categorized into portable and whole-house humidifier. The following are the three types of humidifiers: warm mist humidifier, ultrasonic humidifier, and cool …
- ストレージ仮想化の世界市場2015-2019The increase in implementation of virtualization solutions has led to a rapid development of server virtualization solutions. It increases the productivity of servers and the network as a whole. Technavios market research analysts predict the global storage virtualization market to grow at a CAGR of more than 24% from 2015 to 2019. There need for centralization of all processes in the network and …
- Devon Energy Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Devon Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Devon Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- コネクテッド航空機の世界市場：Kuバンド、Kaバンド、ATG（Air-to-Ground）、機内エンターテイメント、コネクティビティ（IFEC）、IoTVisiongain’s comprehensive new 284 page report reveals that the value of the global connected aircraft market in 2015 will reach $1,851.8m. If you are involved in the connected aircraft market or intend to be, then you must read this report. It’s vital you keep your knowledge up to date. Market scope: With explosive growth in the ownership of Wi-Fi enabled personal electronic devices, there is an …
- Hellenic Petroleum S.A.：石油・ガスバリューチェーン分析レポート2013Hellenic Petroleum S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Hellenic Petroleum S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Hellenic Petroleum S.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The re …
- アメリカのベビー食品・ミルク市場About Baby Food and Formula Infant formula is either a partial or a complete replacement for breast milk for infants aged under one year. It is available in concentrated liquid, powder, or ready-to-use formats. It is provided to meet nutritional needs and encourage the healthy physical and mental development of infants. Baby food products are provided to children up to four years of age. These are …
- アルギニンの世界市場Arginine (CAS 74-79-3) Market Research Report 2013 presents comprehensive data on Arginine markets globally and regionally (Europe, Asia, North America etc.) The Arginine (CAS 74-79-3) Market Research Report 2013 includes Arginine description, covers its application areas and related patterns. It overviews Arginine market, names Arginine producers and indicates its suppliers. Besides, the Arginine …
- 世界の太陽光発電産業動向The use of renewable energy is no longer an out of the ordinary concept. Photovoltaics and solar power are a major resource of producing energy today. In fact, it is estimated that in 2010, solar photovoltaics was used for generating electricity in over 100 countries around the world. However, while it was used in so many countries, the overall percentage of solar photovoltaics only amounted to 4. …
- Inpex Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年）Inpex Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Inpex Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
- 世界のストレージ・ハードウェア（NAS/SAN/DAS）市場（2014-2018）About Hardware Storage Technologies Storage systems are an essential component of any growing enterprise. In the current scenario where insights generated from data drive all the key decisions of a company, having an efficient storage system in place is a necessity. The storage market comprises of three key technologies: NAS, SAN and DAS. All three are critical to the business of any enterprise. T …
- モノのインターネット（IoT）の世界市場2016-2020About the Internet of Things (IoT) Market IoT is a network of physical devices, sensors, and machines integrated into everyday objects connected through the Internet for effective data communications. IoT creates smart communication environments, such as smart healthcare. IoT enhances operational efficiency by increasing the speed of communications compared to the existing infrastructure, thus imp …
- BRIC（ブラジル/ロシア/インド/中国）のカプセル内視鏡システム市場（～2020）BRIC Capsule Endoscopy Systems Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Capsule Endoscopy Systems Market Outlook to 2020", provides key market data on the BRIC Capsule Endoscopy Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Capsule Endoscopes, Capsule Endoscopy Data Recorders …
- フミン酸の世界市場Humic Acid (CAS 1415-93-6) Market Research Report 2013 presents comprehensive data on humic acid markets globally and regionally (Europe, Asia, North America etc.) The Humic Acid (CAS 1415-93-6) Market Research Report 2013 includes humic acid description, covers its application areas and related patterns. It overviews humic acid market, names humic acid producers and indicates its suppliers. Besid …
- 主要先進国における抗高血圧治療市場（～2020）Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries Summary GBI Research, the leading business intelligence provider, has released its latest research, '‘Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expirie …
